Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 6E7] (IgG2b,k) to Human FANCC
IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Rabbit Polyclonal to Human FANCC
Human (tested or 100% immunogen sequence identity)
Specificity and Use
FANCC antibody was raised against a C-Terminal peptide within residues 450-558 of 558. Homology: 100% homology with human protein.92% homology with rat and mouse proteins.81% homology with bovine protein.
Species cross-reactivity: This antibody reacts with the human protein.
FANCC Antibody, FAC Antibody, Fanconi anemia group C protein Antibody, FA3 Antibody, Protein FACC Antibody, FACC Antibody
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.